Background Preterm birth is a global health priority. Using a progestogen during high-risk
pregnancy could reduce preterm birth and adverse neonatal outcomes. Methods We did a …

Background Recent progesterone trials call for an update of previous syntheses of
interventions to prevent preterm birth. Objectives To compare the relative effects of different …

Background Preterm birth is a major complication of pregnancy associated with perinatal
mortality and morbidity. Progesterone for the prevention of preterm labour has been …

Background Multiple pregnancy is a strong risk factor for preterm birth, and more than 50%
of women with a twin pregnancy will give birth prior to 37 weeks' gestation. Infants born …

Background Progesterone administration has been shown to reduce the risk of preterm birth
and neonatal morbidity in women at high risk, but there is uncertainty about longer term …

OBJECTIVE: We sought to provide evidence-based guidelines for using progestogens for
the prevention of preterm birth (PTB). METHODS: Relevant documents, in particular …

OBJECTIVE: We sought to provide evidence-based guidelines for using progestogens for
the prevention of preterm birth (PTB). METHODS: Relevant documents, in particular …

Background The efficacy of vaginal progesterone for preventing preterm birth and adverse
perinatal outcomes in singleton gestations with a short cervix has been questioned after …

Objectives To compare the efficacy of bed rest, cervical cerclage (McDonald, Shirodkar, or
unspecified type of cerclage), cervical pessary, fish oils or omega fatty acids, nutritional …

OBJECTIVE: This study was undertaken to determine whether progestational agents,
initiated in the second trimester of pregnancy, reduce the risk of delivery less than 37 weeks …